Pathophysiology and diagnosis of deep venous thrombosis

Seminars in Nuclear Medicine

Volumn 31, Issue 2, 2001, Pages 90-101

  Line, Bruce R ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Department of Diagnostic Radiology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEEP VEIN THROMBOSIS; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCOAGULABILITY; LUNG EMBOLISM; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; PHLEBOGRAPHY; PLETHYSMOGRAPHY; REVIEW; RISK FACTOR; UNITED STATES;

EID: 0035047853     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/snuc.2001.21406     Document Type: Article

References (96)

1. Physician practices in the management of venous thromboembolism: A community-wide survey
2. Deep vein thrombosis and pulmonary embolism: Prevention, diagnosis, and treatment
3. Venous thromboembolic disease: The role of US
4. The structure and growth of valve pocket thrombi in femoral veins
5. Factor IX is activated in vivo by the tissue factor mechanism
6. Venous endothelial leukocytes
7. Untersuchungen iiber thrombose
8. The epidemiology, pathogenesis and natural history of venous thrombosis
9. Natural history of postoperative deep-vein thrombosis
10. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis
11. Venous thrombosis: Analysis of 580 cases
12. The long-term clinical course of acute deep venous thrombosis
13. Die verstopfund den lungenarteries und ihre folgen
14. Hypoxia mediates the barrier and coagulant function of bovine endothelium: Increased monolayer permeability and induction of procoagulant properties
15. Effect of bedrest on resting calf blood flow of healthy adult males
16. Early post-operative ambulation
17. Venous thrombosis in the lower limbs with particular reference to bedrest
18. The impact of prophylactic measures in fatal pulmonary embolism
19. Thrombus production by turbulence
20. Measured turbulence and its effect on thrombus formation
21. Venous stasis in the lower extremities
22. 33-Thromboglobulin: A new tool for the diagnosis of hypercoagulability?
23. Venous thromboembolism in association with prolonged air travel
24. Venous thromboembolism and travel: Is there an association
25. Postmortem intraosseous phlebography as an aid in studies of venous thromboembolism
26. Postmortem intraosseous phlebography as an aid in studies of venous thromboembolism
27. Prospective study of exogenous hormones and risk of pulmonary embolism in women
28. Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency
29. Protein C: The regulation of natural anticoagulant pathways
30. The role of the fibrinolytic system in deep vein thrombosis
31. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis
32. The effect of anticoagulants on postoperative fibrinogen metabolism. Secondary anaemias, XVI
33. Fibrinogen metabolism following injury and its surgical treatment
34. A study of the metabolism of fibrinogen after surgical operations
35. Relationship between fibrinogen and blood viscosity
36. 506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency
37. Actions and interactions of antithrombin and heparin
38. Heparin antithrombin and abnormal clotting
39. Deficiency of antithrombin 111 activity associated with hereditary thrombosis tendency
40. Variations in antithrombin activity in plasma after major surgery
41. Postoperative antithrombin III concentration
42. Oral contraceptives and low antithrombin 111 activity
43. 506 to Gin mutation in factor V as a pathogenic risk factor for venous thrombosis
44. Tissue activators of plasminogen
45. Defective fibrinolysis in blood vein walls in recurrent "idiopathic" venous thrombosis
46. A critical review of the evidence supporting a relationship between impaired fibrinolysis and venous thromboembolism
47. A comparative study of blood fibrinolytic activity in normal women, pregnant women and women on oral contraceptives
48. Fibrinolysis in obesity
49. Thymic uptake of gallium-67 citrate in a healthy 4-year-old boy
50. Barriers to xenotransplantation
51. An evaluation of clinical signs in the diagnosis of venous thrombosis
52. Problems of acute deep venous thrombosis. I. The interpretation of signs and symptoms
53. Accuracy of clinical assessment of deep-vein thrombosis
54. The incidence of deep vein thrombosis
55. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis
56. Different intensities of anticoagulation in the long-term treatment of proximal vein thrombosis
57. Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis: A randomized trial
58. Prevention of venous thromboembolism
59. Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis: A randomized trial
60. Adjusted subcutaneous heparin vs warfarin sodium in the long-term treatment of venous thrombosis
61. The diagnosis of acute recurrent DVT: A diagnostic challenge
62. Utility of impedance plethysmography in the diagnosis of recurrent deep-vein thrombosis
63. Long-term sequelae of acute venous thrombosis
64. Iliac vein compression: Its relation to iliofemoral thrombosis and the post-thrombotic syndrome
65. The post thrombotic syndrome
66. The post-phlebitic syndrome management by conservative means
67. Urokinase Streptokinase Embolism Trial: Phase II results. A cooperative study
68. Serial impedance plethysmography for suspected deep venous thrombosis in outpatients: The Amsterdam General Practitioner Study
69. Comparison of the accuracy of impedance plethysmography and compression ultrasonography in outpatients with clinically suspected deep vein thrombosis: A two center paired-design prospective trial
70. DVT evaluation with limited flip-angle, gradient refocused MRI: Preliminary experience
71. DVT of extremities. Role of MRI in the diagnosis
72. Lower extremity venography
73. Phlebography as the gold standard in thromboprophylactic studies? A multicenter interobserver variation study
74. Diagnosis of deep-vein thrombosis using duplex ultrasound
75. Diagnosis of deep venous thrombosis. A prospective study comparing duplex scanning to contrast venography
76. Duplex B-mode imaging for the diagnosis of deep venous thrombosis
77. Duplex ultrasound diagnosis of lower limb venous thrombosis
78. Pitfalls in lower extremity venous duplex scanning
79. Color Doppler ultrasound imaging of lower-extremity venous disease
80. Compression ultrasonography as a reliable imaging monitor in deep venous thrombosis
81. Ultrasound evaluation of deep venous thrombosis
82. Deep venous thrombosis of the leg
83. Real-time B-mode venous ultrasound
84. Iliofemoral venous thrombosis: Real-time ultrasound diagnosis, normal criteria, and clinical application
85. Perioperative asymptomatic venous thrombosis: Role of duplex scanning versus venography
86. The comparative value of non-invasive testing for diagnosis and surveillance of deep vein thrombosis
87. Symptomatic lower extremity deep venous thrombosis: Accuracy, limitations, and role of color duplex flow imaging in diagnosis
88. Color Doppler ultrasound imaging of lower-extremity venous disease
89. Image-directed Doppler ultrasound: A screening technique for patients at high risk to develop deep vein thrombosis
90. Accuracy of clinical assessment of deep-vein thrombosis
91. Correlation of the echogenicity and structure of clotted blood
92. B-mode sonography of blood clots
93. Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery: A meta-analysis
94. Venous thrombosis in patients who have undergone major hip or knee surgery: Detection with compression US and impedance plethysmography
95. Low accuracy of color Doppler ultrasound in detection of proximal leg vein thrombosis in asymptomatic high-risk patients
96. Progress in the diagnosis of deep venous thrombosis